Document
IPR2015-01096, No. 2002 Exhibit - Dr V Pannikar, WHO The Return of Thalidomide New Uses and Renewed Concerns (P.T.A.B. Jul. 30, 2015)
Cite Document
IPR2015-01096, No. 2002 Exhibit - Dr V Pannikar, WHO The Return of Thalidomide New Uses and Renewed Concerns (P.T.A.B. Jul. 30, 2015)
+ More Snippets
Document
IPR2015-01096, No. 2015 Exhibit - Celgene January 2005 Form 8 K (P.T.A.B. Jul. 30, 2015)
Cite Document
IPR2015-01096, No. 2015 Exhibit - Celgene January 2005 Form 8 K (P.T.A.B. Jul. 30, 2015)
+ More Snippets
Document
IPR2015-01096, No. 2046 Exhibit - July 2014 IRDP threatened 720 patent anticipation IPR petition (P.T.A.B. Jul. 30, 2015)
Cite Document
IPR2015-01096, No. 2046 Exhibit - July 2014 IRDP threatened 720 patent anticipation IPR petition (P.T.A.B. Jul. 30, 2015)
+ More Snippets
Document
IPR2015-01096, No. 2019 Exhibit - FDA Orphan Drug Designations and Approvals for Lenalidomide (P.T.A.B. Jul. 30, 2015)
Cite Document
IPR2015-01096, No. 2019 Exhibit - FDA Orphan Drug Designations and Approvals for Lenalidomide (P.T.A.B. Jul. 30, 2015)
+ More Snippets
Document
IPR2015-01096, No. 1009 Exhibit - Cunningham (P.T.A.B. Apr. 23, 2015)
Cite Document
IPR2015-01096, No. 1009 Exhibit - Cunningham (P.T.A.B. Apr. 23, 2015)
+ More Snippets
Document
IPR2015-01096, No. 1038 Exhibit - Thalomid OB Patents (P.T.A.B. Aug. 13, 2015)
Cite Document
IPR2015-01096, No. 1038 Exhibit - Thalomid OB Patents (P.T.A.B. Aug. 13, 2015)
+ More Snippets
Document
IPR2015-01096, No. 1045 Exhibit - CEPR Study Cost of Pharma IPR exemption (P.T.A.B. Aug. 13, 2015)
Cite Document
IPR2015-01096, No. 1045 Exhibit - CEPR Study Cost of Pharma IPR exemption (P.T.A.B. Aug. 13, 2015)
+ More Snippets
Document
IPR2015-01096, No. 2053 Exhibit - IP Watchdog Senator Coons Patents Are about the American Dream 2015 (P.T.A.B. Jul. 30, 2015)
Cite Document
IPR2015-01096, No. 2053 Exhibit - IP Watchdog Senator Coons Patents Are about the American Dream 2015 (P.T.A.B. Jul. 30, 2015)
+ More Snippets
Document
IPR2015-01096, No. 2068-2 Exhibit - Declaration of John Freeman, Corporate VP, Head of Global Drug Safety and Risk Management, Celgene Corporation (P.T.A.B. Feb. 16, 2016)
Cite Document
IPR2015-01096, No. 2068-2 Exhibit - Declaration of John Freeman, Corporate VP, Head of Global Drug Safety and Risk Management, Celgene Corporation (P.T.A.B. Feb. 16, 2016)
+ More Snippets
Document
IPR2015-01096, No. 1068 Exhibit - Federal Register Volume 62, Number 53 (P.T.A.B. Jan. 25, 2016)
Cite Document
IPR2015-01096, No. 1068 Exhibit - Federal Register Volume 62, Number 53 (P.T.A.B. Jan. 25, 2016)
+ More Snippets
Document
IPR2015-01096, No. 1035 Exhibit - Bricklayers v Celgene Antitrust complaint (P.T.A.B. Aug. 13, 2015)
Cite Document
IPR2015-01096, No. 1035 Exhibit - Bricklayers v Celgene Antitrust complaint (P.T.A.B. Aug. 13, 2015)
+ More Snippets
Document
IPR2015-01096, No. 1073 Exhibit - 2013 Rho Chi Lecture Writing the Headlines of Tomorrow (P.T.A.B. May. 27, 2016)
Cite Document
IPR2015-01096, No. 1073 Exhibit - 2013 Rho Chi Lecture Writing the Headlines of Tomorrow (P.T.A.B. May. 27, 2016)
+ More Snippets
Document
IPR2015-01096, No. 1072 Exhibit - Managing the teratogenic risk of thalidomide and lenalidomide an industry perspective (P.T.A.B. May. 27, 2016)
Cite Document
IPR2015-01096, No. 1072 Exhibit - Managing the teratogenic risk of thalidomide and lenalidomide an industry perspective (P.T.A.B. May. 27, 2016)
+ More Snippets
Document
IPR2015-01096, No. 1075-2 Exhibit - Frau Transcript Volume 1 and 2 PUBLIC (P.T.A.B. May. 27, 2016)
Cite Document
IPR2015-01096, No. 1075-2 Exhibit - Frau Transcript Volume 1 and 2 PUBLIC (P.T.A.B. May. 27, 2016)
+ More Snippets
Document
IPR2015-01096, No. 1076 Exhibit - Ctr Drug Eval Research, FDA, Transcript 47th Derm and Opth Drugs Advisory 1997 (P.T.A.B. May. 27, 2016)
Cite Document
IPR2015-01096, No. 1076 Exhibit - Ctr Drug Eval Research, FDA, Transcript 47th Derm and Opth Drugs Advisory 1997 (P.T.A.B. May. 27, 2016)
+ More Snippets